Failure of a serotonergic receptor-blocking drug to change the twenty-four-hour luteinizing hormone secretory pattern in women. 1980

S Kapen, and A Vagenakis, and L Braverman

The 24-h LH secretory pattern in women during the early follicular phase is characterized by inhibition during the early sleep period. Methysergide maleate was administered to six normal women to test the hypothesis that the effect of sleep on LH secretion is due to serotonergic mechanisms. The results demonstrated no change in the sleep effect on LH secretion after drug administration. The 4-h average deviation after sleep onset from the 24-h mean was -27.7% for the control studies and -25.5% after methysergide maleate. The data suggest tht serotonergic pathways are not critically involved in the control of the 24-h LH secretory program in women.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D008784 Methysergide An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. Dimethylergometrin,Methylmethylergonovine,Deseril,Desril,Désernil-Sandoz,Methysergide Dimaleate,Methysergide Maleate,Sansert,UML-491,Dimaleate, Methysergide,Désernil Sandoz,Maleate, Methysergide,UML 491,UML491
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit
D014851 Wakefulness A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli. Wakefulnesses

Related Publications

S Kapen, and A Vagenakis, and L Braverman
February 1987, Endocrinologia japonica,
S Kapen, and A Vagenakis, and L Braverman
October 1973, The Journal of clinical endocrinology and metabolism,
S Kapen, and A Vagenakis, and L Braverman
August 1987, Acta endocrinologica,
S Kapen, and A Vagenakis, and L Braverman
July 1972, The Journal of clinical endocrinology and metabolism,
S Kapen, and A Vagenakis, and L Braverman
June 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
S Kapen, and A Vagenakis, and L Braverman
November 1994, Stroke,
S Kapen, and A Vagenakis, and L Braverman
January 1992, Neuropsychobiology,
S Kapen, and A Vagenakis, and L Braverman
January 1974, Annales d'endocrinologie,
Copied contents to your clipboard!